Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |